| pubmed-article:686617 | pubmed:abstractText | Lamprene (Clofazimine) was administered over a period of three months, at a dose of 100 mg to 200 mg per day, to six patients with chronic lupus erythematosus. Remission was observed in these six cases, without any side-effect. | lld:pubmed |
